Skip to content

The effect of dental adhesive/dental gel containing monocaprin on Candida infection in the mouth

A study of the effect of monocaprin in dental adhesive/dental gel on Candida infection in the oral cavity

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2012-005216-26-IS
Enrollment
Unknown
Registered
2013-01-23
Start date
2013-02-13
Completion date
Unknown
Last updated
2015-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic atrophic candidosis or denture stomatitis is the commonest form of oral candidosis. It is an opportunistic infection related to an inflammatory process in the mucosal surface beneath dentures and is a common finding among edentulous patients attending dental schools and those resident in homes for the elderly. The prevalence of this type of candidosis has been increasing with more than 50% of subjects in some studies of elderly denture wearers being reported to have candidosis.

Interventions

Product Name: Monocaprin dental paste Pharmaceutical Form: Dental paste Product Name: Monocarpin gel Pharmaceutical Form: Dental gel

Sponsors

Faculty of Odontology, University of Iceland
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The study will be carried out at the clinic of the Landakot geriatric hospital and the dental clinic of the Faculty of Odontology at the University of Iceland. Subjects will be selected from the group of patients attending the clinic. Patients will be edentulous in the upper jaw and use their dentures routinely. The study will be explained to each individual by the pharmacy students, with supervision and assistance where necessary. Patients must give their informed consent to the study. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 60

Exclusion criteria

Exclusion criteria: Participants that are cognitively impared will be excluded from the trial.

Design outcomes

Primary

MeasureTime frame
Main Objective: The applicants have been investigating several new methods for treating common conditions of the oral mucosa. One particular area of interest follows on from the demonstration that monocaprin, a derivative of capric acid, is active against oral yeasts and has, therefore, potential as an alternative treatment for oral yeast infections such as chronic atrophic candidosis or denture stomatitis. The aim of this study is to follow on from the previously-demonstrated in vitro anti-candidal activity into a clinical study by incorporating monocaprin into denture adhesives and mucoadhesive hydrogel. These products will then be tested in clinical trials. It is hoped that these denture products would be improved by imparting anti-candidal activity adjacent to the oral mucosa.;Secondary Objective: Not applicable;Primary end point(s): There will be 60 participants in the study and they will be divided into three groups with 20 participants in each. Group I will receive treatement with dental adhesive containing monocaprin, group II will receive treament with tissue liner containing monocaprin and Group III will be not receive treatment but will function as control. The study will last for four weeks. The participants will be taught how to use the dental adhesive and the mucoadhesive hydrogel and requested to use the monocaprin-containing preparations daily. Speciments will be taken at the beginning of the study, then in two weeks and in four weeks. Speciments will be taken at the beginning of the study, then in two weeks and in four weeks. Specimens will be collected using standard 1sq cm sponges that have been soaked in sterile saline and, using sterile tweezers, placed on i) the fitting surface of the denture; ii) the dorsum of the tongue and iii) the palatal mucosa for about 15 sec. Swabs are then removed and placed on the surface of agar culture plates. Plates will be transferred to the laboratory in the Faculty of Odontology and incubated at 37°C overnig

Secondary

MeasureTime frame
Secondary end point(s): Speciments will be taken at the beginning of the study, then in two weeks and in four weeks. ;Timepoint(s) of evaluation of this end point: Two weeks after the termination of treatment with monocaprin containing preparations speciments will be taken to evaluated the extent of re-colonisation.

Countries

Iceland

Contacts

Public ContactW. Peter Holbrook

Faculty of Odontology, University of Iceland

phol@hi.is3545254850

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026